GlassScriptPhysician profile
Brian David Ku
NPI 1235591702
$8,959.80
in general payments reported to CMS, 2019-2025
60 companies · $2,029 in 2025
The $2,029 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $42.52 · 2022: $1,239 · 2023: $2,509 · 2024: $3,141 · 2025: $2,029.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,184 · Consulting Fee: $350 · Education: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,183.59 |
| Consulting Fee | $350.00 |
| Education | $145.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $1,147.43 | 2022-2025 | Briviact, Rystiggo, Fintepla |
| Abbvie INC. | $1,025.62 | 2022-2025 | |
| Acadia Pharmaceuticals INC | $398.65 | 2023-2025 | Nuplazid, Daybue |
| Pfizer INC. | $391.56 | 2023-2025 | |
| Merz Pharmaceuticals, LLC | $309.50 | 2022-2024 | Xeomin |
| Jazz Pharmaceuticals INC. | $292.72 | 2022-2025 | |
| Lundbeck LLC | $277.60 | 2023-2025 | Vyepti, Rexulti |
| Harmony Biosciences LLC | $275.51 | 2022-2025 | Wakix |
| Lilly USA, LLC | $262.75 | 2022-2025 | Amyvid, Emgality, Kisunla |
| Sumitomo Pharma America, INC. | $262.10 | 2023-2024 | Aptiom |
| Inspire Medical Systems, INC. | $249.28 | 2023-2025 | Inspire |
| Avadel Cns Pharmaceuticals, LLC | $246.33 | 2023-2025 | Lumryz |
| Eisai INC. | $240.86 | 2022-2025 | |
| Teva Pharmaceuticals USA, INC. | $232.05 | 2022-2025 | Austedo Xr, Austedo Xr, Austedo |
| Alexion Pharmaceuticals, INC. | $226.83 | 2022-2024 | Ultomiris, Soliris |
Show all 60 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $223.07 | 2022-2025 | Ingrezza, Ongentys |
| Argenx US, INC. | $181.62 | 2023-2025 | Vyvgart Hytrulo, Vyvgart |
| Neurelis, INC. | $175.65 | 2023-2025 | Valtoco |
| Octapharma USA, INC. | $162.60 | 2022-2024 | Panzyga, Octagam Immune Globulin (Human) |
| Celgene Corporation | $157.40 | 2022-2025 | Zeposia |
| Vanda Pharmaceuticals INC. | $151.39 | 2024-2025 | Ponvory |
| Sk Life Science, INC. | $143.12 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $136.54 | 2022-2025 | |
| Ipsen Biopharmaceuticals, INC | $129.04 | 2022-2024 | Dysport |
| Csl Behring | $118.64 | 2022-2025 | Hizentra, Privigen |
| Itamar Medical INC | $112.39 | 2022 | |
| Alnylam Pharmaceuticals INC. | $108.92 | 2022-2025 | Onpattro |
| Immedica Pharma US, INC. | $98.06 | 2024 | |
| Corium, LLC | $94.79 | 2023 | Adlarity |
| Tg Therapeutics, INC. | $78.98 | 2024 | |
| Abbott Laboratories | $66.78 | 2022-2025 | Proclaim |
| Amneal Pharmaceuticals LLC | $65.77 | 2022-2024 | Rytary |
| Biogen, INC. | $65.60 | 2022-2025 | Skyclarys, Tysabri |
| Ensodata, INC. | $64.55 | 2025 | |
| Scilex Pharmaceuticals INC. | $64.02 | 2024 | |
| Avion Pharmaceuticals | $59.41 | 2022-2023 | Dhivy |
| Biohaven Pharmaceutical Holding Company LTD. | $58.72 | 2022 | |
| Tanabe Pharma America, INC. | $58.53 | 2022-2024 | |
| Sunovion Pharmaceuticals INC. | $49.32 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $42.31 | 2024-2025 | Hyqvia |
| Kedrion Biopharma, INC. | $40.18 | 2024 | Gammaked, Kedrab, Koate |
| Emd Serono, INC. | $36.30 | 2022-2023 | Mavenclad |
| Springworks Therapeutics, INC. | $36.03 | 2025 | Gomekli |
| Upsher-Smith Laboratories LLC | $34.21 | 2022 | |
| Janssen Pharmaceuticals, INC | $30.80 | 2022 | |
| Kyowa Kirin, INC. | $29.09 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $23.96 | 2023 | Andexxa |
| Genentech USA, INC. | $23.68 | 2022 | |
| Grifols USA, LLC | $21.39 | 2024 | Gamunex-C |
| Life Molecular Imaging LTD | $20.29 | 2024 | Neuraceq |
| 3b Medical, INC. | $20.26 | 2025 | Luna |
| Otsuka America Pharmaceutical, INC. | $18.01 | 2023 | Nuedexta |
| Impel Pharmaceuticals INC. | $17.61 | 2023 | Trudhesa |
| Catalyst Pharmaceuticals, INC. | $17.21 | 2025 | |
| Tonix Medicines, INC. | $15.22 | 2025 | Zembrace Symtouch |
| Horizon Therapeutics Plc | $15.21 | 2022 | |
| Ani Pharmaceuticals, INC. | $14.83 | 2024 | Purified Cortrophin Gel |
| Ge Healthcare | $14.24 | 2024 | |
| Biohaven Pharmaceuticals, INC. | $13.43 | 2021 | |
| Xeris Pharmaceuticals, INC. | $11.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Ku listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.